Vanrx
Vanrx Pharmasystems supplies Annex 1-compliant robotised fill-finish platforms (Microcell robocell) that let sponsors run small sterile batches with almost no operator intervention, ideal for cell therapies and clinical supply.
- Country
- United States
Commercial
Robotic Fill-Finish
Coverage
| CN | EU | US | |
|---|---|---|---|
| fill-finish-packaging | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aseptic filling lines | fill-finish-packaging | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.